ADVERTISEMENT
Europe's Energy Crisis Has A Collateral Benefit For Indian Drugmakers
Europe's energy crunch is hurting power-intensive sectors, including its pharmaceutical industry.
13 Sep 2022, 12:03 PM IST
Europe's energy crunch is hurting power-intensive sectors, including its pharmaceutical industry. And that might present an opportunity for India's bulk drugmakers.A severe energy crisis is looming over Europe due to Russia choking off gas supplies, forcing factories to shut down and power plants to run at reduced capacity leading to astronomical electricity bills.Power prices in Europe have escalated 8-10 times and this would, in tu...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT